Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 300-227-8 | CAS number: 93924-33-5 A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190°C to 330°C (374°F to 594°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
This endpoint is not a REACH requirement.
Additional information
Read-across to the two-generation reproduction toxicity test (OECD 416) proposed for Straight Run Gas OIls is intended to fulfill the data requirement for category members which are not classified as carcinogens. Compositional and physico-chemical data show that Straight-Run Gas Oils are very similar to Other Gas Oils. It is considered appropriate, therefore, to read across from the SRGO data to Other Gas Oils.
According to Column 2 of Annex IX for this endpoint, a two-generation reproductive toxicity study does not need to be conducted if the substance is known to be a genotoxic carcinogen and appropriate risk management measures are implemented. Accordingly, for substances within the Other Gas Oils category classified as Category 1B carcinogens according to EU CLP (EC No. 1272/2008) criteria, further investigations of effects on fertility for substances classifed as Category 1B carcinogens are not required.
In a supporting read-across study, groups of female Sprague-Dawley rats received 0 (sham control), 1, 259 or 1036 mg/kg body weight/day of VDF gas oil dermally (ARCO, 1994a; Klimisch score = 2). Treatment of the females commenced one week prior to mating with untreated males. Pregnant females were then assigned to the test (n = 15/dose level) and control groups (n = 20) and treatment continued until gestation day (GD) 20.
None of the dams died during the course of the study. Dermal irritation was present at the treatment site in the mid- and high-dose groups. Mean body weight, weight gain, and food consumption were also reduced in these groups. None of the high-dose females delivered live pups and there was a significant decrease in the number of live pups at other doses on lactation day 0. Mean pup weight was significantly reduced at birth and at lactation day 4 for the mid-dose litters, no toxicologically relevant effects were reported for the offspring. Based on these results, the authors of the study determined a NOAEL of 1 mg/kg body weight/day for effects of VDF gas oil on foetal/pup development (reduced body weight of live pups/ litter and the number of live pups) and a NOAEL of 1 mg/kg bw/day for female fertility effects and maternal toxicity.
Short description of key information:
Read-across to the two-generation reproduction toxicity test (OECD 416) proposed for Straight Run Gas Oils is intended to fulfill the data requirement for substances within the Other Gas Oils category which are not classified as carcinogens.
According to Column 2 of Annex IX for this endpoint, a two-generation reproductive toxicity study does not need to be conducted if the substance is known to be a genotoxic carcinogen and appropriate risk management measures are implemented. Accordingly, for substances within the Other Gas Oils category classified as Category 1B carcinogens according to EU CLP (EC No. 1272/2008) criteria, further investigations of effects on fertility are not required.
A supporting screening read-across study (non-guideline) was identified in which rats were dermally administered VDF gas oil. Females began treatment one week prior to mating and treatment continued until gestation day 20. Based on these results, the authors of the study determined a NOAEL of 1 mg/kg body weight/day (i.e., the low dose) for effects of VDF gas oil on female fertility and maternal toxicity.
Effects on developmental toxicity
Description of key information
In a read across developmental study from heavy atmospheric gas oil, authors reported a NOAEL of 30 mg/kg body weight/day for maternal toxicity and foetal toxicity applicable to Other Gas Oils.
Effect on developmental toxicity: via dermal route
- Dose descriptor:
- NOAEL
- 30 mg/kg bw/day
Additional information
No studies were located for other gas oils. However information from a dermal study in rats on a straight run gas oil (Heavy atmospheric gas oil; CAS 68915-97-9) may be used as a source of information for read across. Straight run gas oil data can be used as read-across data for other gas oils due to similar physical/chemical properties and composition.
The developmental toxicity of heavy atmospheric gas oil (straight run, high boiling distillate) was investigated using two sets of pregnant SD rats. Animals from the first experimental series (termed the prenatal group) were treated with the test material at doses of 0 (sham control), 8, 30, 125, or 500 mg/kg body weight/day on gestation days (GD) 0-19, and sacrificed on GD 20. The second experimental series (termed the postnatal group) received 0 or 125 mg/kg body weight/day on GD 0-19, were allowed to deliver their pups normally, and both dams and pups were sacrificed on lactation day (LD) 4.
Daily application of heavy atmospheric gas oil produced dermal irritation (erythema, thickening of skin, oedema, flaking, scabbing) at the site of application in some animals (infrequent at the lowest dose) but no irritation scores were provided in the report and hence the impact of these reactions on pregnancy outcome cannot be judged directly. Red vaginal discharge was observed in 7 pregnant females from the 500 mg/kg body weight/day dose prenatal group, and in 1 female given 125 mg/kg body weight/day from both the prenatal and postnatal groups. This finding was considered by the study authors to be test material related and indicative of some degree of litter resorption.
Maternal body weights were decreased significantly by approx. 6% or 26% in dams from the prenatal groups treated with 125 or 500 mg/kg body weight/day, respectively, on gestation days 13 and 20. Females from the postnatal group receiving 125 mg/kg body weight/day also gained significantly less weight during the first half of the gestation period (26-75% reduction in body weight change relative to the controls). Mean relative thymus weight was significantly decreased (by approximately 53% compared to controls), and mean relative liver weight significantly increased (by approximately 17% compared to controls), in prenatal females from the 500 mg/kg body weight/day group. Serum chemistry parameters were altered in high-dose animals from the prenatal series, and a linear relationship was observed between dose and serum level for triglycerides, total protein, albumin, calcium, urea nitrogen, and alkaline phosphatase. The study authors reported that dose-response curves for these parameters fell outside the normal range in comparison to historical data but no further details were provided. There was also a reduction of segmented neutrophils and platelets in animals treated with 125 and 500 mg/kg/bw/day heavy atmospheric gas oil, respectively.
A statistically significant increase in mean number/percent of resorptions (108/65.6%) with a corresponding decrease in mean litter size (3.6) was observed at the 500 mg/kg body weight/day dose level when compared to control animals (8/5.0% and 14.9, respectively). All foetuses from the 500 mg/kg body weight/day as well as the male foetuses from the 125 mg/kg bw/day groups (mean body weights 3.0 and 3.6 g, respectively) weighed significantly less than control foetuses (3.8 and 3.9 g, respectively).
Skeletal examination revealed incomplete ossification of a number of structures (nasal bones, thoracic centra, caudal centra, sternebrae, metatarsals, and pubis) in foetuses from the 125 mg/kg body weight/day (83% incidence) and 500 mg/kg body weight/day (100% incidence) groups, which were stated to be significantly increased relative to the controls (66% incidence). The incidence of all of these structural findings was significantly raised in the 500 mg/kg/day group while the occurrence of incompletely ossified nasal bones and thoracic centra was increased in the 125 mg/kg/day group. No visceral anomalies or adverse effects on pup development or survival were reported, however pup body weight and body weight gain were significantly lower in the 125 mg/kg body weight/day group from the postnatal phase of the study (5.8 g on LD 0; 8.7 g on LD 4) relative to the controls (6.2 g on LD 0; 9.7 g on LD 4).
The study authors reported a NOAEL of 30 mg/kg body weight/day for maternal toxicity (decreased body weight, haematological changes) and foetal toxicity (increased resorption, incomplete skeletal ossification, decreased foetal weights, decreased litter size) following repeated dermal application of heavy atmospheric gas oil on GD 0-19. There were no adverse effects on postnatal development (LD 0-4). Although limited reporting means it is not possible to determine whether dermal irritation contributed to these findings, results from a sub-chronic dermal toxicity study on heavy atmospheric gas oil suggest this would not have been expected to have been present to any significant extent in dams from the 125 mg/kg body weight/day groups, indicating the effects observed at this dose level were test substance-related.
Toxicity to reproduction: other studies
Additional information
This endpoint is not a REACH requirement.
Justification for classification or non-classification
A key developmental study on heavy atmospheric gas oil was identified. The NOEL for both maternal and foetal toxicity was 30mg/kg. No classification for effects on development is proposed however since there was no evidence of foetal effects in the absence of significant maternal toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
